Impact of Traditional Plants and their Secondary Metabolites in the Discovery of COVID-19 Treatment
- PMID: 33213320
- DOI: 10.2174/1381612826666201118103416
Impact of Traditional Plants and their Secondary Metabolites in the Discovery of COVID-19 Treatment
Abstract
Background: Coronavirus Disease-2019 belongs to the family of viruses which cause serious pneumonia along with fever, breathing issues and infection of lungs, and was first reported in China and later spread worldwide.
Objective: Several studies and clinical trials have been conducted to identify potential drugs and vaccines for Coronavirus Disease-2019. The present study listed natural secondary metabolites identified from plant sources with antiviral properties and could be a safer and tolerable treatment for Coronavirus Disease-2019.
Methods: A comprehensive search on the reported studies was conducted using different search engines such as Google Scholar, SciFinder, Sciencedirect, Medline PubMed, and Scopus for the collection of research articles based on plant-derived secondary metabolites, herbal extracts, and traditional medicine for coronavirus infections.
Results: Status of COVID-19 worldwide and information of important molecular targets involved in COVID- 19 are described, and through literature search, it is highlighted that numerous plant species and their extracts possess antiviral properties and are studied with respect to coronavirus treatments. Chemical information, plant source, test system type with a mechanism of action for each secondary metabolite are also mentioned in this review paper.
Conclusion: The present review has listed plants that have presented antiviral potential in the previous coronavirus pandemics and their secondary metabolites, which could be significant for the development of novel and a safer drug which could prevent and cure coronavirus infection worldwide.
Keywords: COVID-19; TCM; coronavirus; dietary supplementation; herbal medicine; plant; secondary metabolites.
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Similar articles
-
An Update on Promising Agents against COVID-19: Secondary Metabolites and Mechanistic Aspects.Curr Pharm Des. 2022;28(29):2415-2425. doi: 10.2174/1381612828666220722124826. Curr Pharm Des. 2022. PMID: 35899955
-
Phytotherapic Drugs for COVID-19 Treatment: A Scoping Review.Curr Pharm Des. 2021 Oct 5;27(31):3389-3398. doi: 10.2174/1381612827666210705163807. Curr Pharm Des. 2021. PMID: 34225610
-
Natural therapeutics and nutraceuticals for lung diseases: Traditional significance, phytochemistry, and pharmacology.Biomed Pharmacother. 2022 Jun;150:113041. doi: 10.1016/j.biopha.2022.113041. Epub 2022 May 6. Biomed Pharmacother. 2022. PMID: 35658211 Review.
-
[Research progress of intervention of Chinese herbal medicine and its active components on human coronavirus].Zhongguo Zhong Yao Za Zhi. 2020 Mar;45(6):1263-1271. doi: 10.19540/j.cnki.cjcmm.20200219.501. Zhongguo Zhong Yao Za Zhi. 2020. PMID: 32281335 Review. Chinese.
-
Natural products for COVID-19 prevention and treatment regarding to previous coronavirus infections and novel studies.Phytother Res. 2021 Feb;35(2):864-876. doi: 10.1002/ptr.6873. Epub 2020 Sep 27. Phytother Res. 2021. PMID: 32985017 Review.
Cited by
-
Non-nucleoside structured compounds with antiviral activity-past 10 years (2010-2020).Eur J Med Chem. 2022 Mar 5;231:114136. doi: 10.1016/j.ejmech.2022.114136. Epub 2022 Jan 19. Eur J Med Chem. 2022. PMID: 35085926 Free PMC article. Review.
-
A comprehensive perspective of traditional Arabic or Islamic medicinal plants as an adjuvant therapy against COVID-19.Saudi J Biol Sci. 2023 Mar;30(3):103561. doi: 10.1016/j.sjbs.2023.103561. Epub 2023 Jan 13. Saudi J Biol Sci. 2023. PMID: 36684115 Free PMC article. Review.
-
Plant Cell-Engineered Gold Nanoparticles Conjugated to Quercetin Inhibit SARS-CoV-2 and HSV-1 Entry.Int J Mol Sci. 2023 Sep 30;24(19):14792. doi: 10.3390/ijms241914792. Int J Mol Sci. 2023. PMID: 37834240 Free PMC article.
-
Modern drug discovery applications for the identification of novel candidates for COVID-19 infections.Ann Med Surg (Lond). 2022 Aug;80:104125. doi: 10.1016/j.amsu.2022.104125. Epub 2022 Jul 12. Ann Med Surg (Lond). 2022. PMID: 35845863 Free PMC article. Review.
-
Scientometric assessment of scientific documents published in 2020 on herbal medicines used for COVID-19.J Herb Med. 2022 Sep;35:100588. doi: 10.1016/j.hermed.2022.100588. Epub 2022 Jul 11. J Herb Med. 2022. PMID: 35847990 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources